FOR IMMEDIATE RELEASE
Tuesday, August 20, 2002 |
CONTACT:
HRSA PRESS OFFICE
301-443-3376 |
HRSA Welcomes HIV/AIDS Health Care Providers to Biennial
Conference;
Studies Find That While Patients in Federal Programs Are Mostly Minorities,
Those Groups Still Face Barriers to Accessing HIV/AIDS Care
The Health Resources and Services Administration (HRSA) today welcomed
HIV/AIDS health care providers from around the country to its 2002 Ryan
White Comprehensive AIDS Resources Emergency (CARE) Act Grantee Conference
in Washington, D.C. Federal CARE Act programs fund primary care and
support services for individuals living with HIV who lack health insurance
and financial resources for their care.
Attendees to the biennial conference learned in just-released reports
that while CARE Act programs serve predominantly minority populations
– almost seven in 10 of the more than 530,000 served annually are racial
or ethnic minorities – those same groups continue to face policy and
social barriers to obtaining HIV/AIDS care and services.
As an agency of the Department of Health and Human Services, HRSA administers
CARE Act programs, whose fiscal year 2002 appropriation was $1.91 billion.
Information on the CARE Act’s impact on AIDS in the United States
is contained in HRSA’s annual report, "The AIDS Epidemic and
the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act--Progress
Report, 2002."
Meanwhile, four new studies funded by HRSA and conducted mainly by
University of California-San Francisco (UC-SF) researchers found continuing
disparities among racial and ethnic groups’ access to HIV care and HIV
drugs. The studies, which will appear in the September edition
of the journal Public Health Reports, identified these key barriers
to minorities’ access of HIV health care services: restrictive eligibility
criteria for public insurance; income and benefit limits in State programs;
lack of information; distrust of government; and HIV-related stigma.
“Our CARE Act programs provide more than half a million poor or uninsured
Americans living with HIV/AIDS access to the best available clinical
treatment,” said HRSA Administrator Elizabeth M. Duke. “We recognize
that some problems remain in accessing HIV treatment and services, but
we know, too, that CARE Act grantees do an exceptional job in breaking
down barriers and reaching out to those who need care most.”
In 2000, CARE Act programs funded more than 4 million patient visits
through its two largest programs: Title I grants to Eligible Metropolitan
Areas and Title II grants to States and Territories. That year, 69 percent
of all CARE Act clients were minority, up from 66 percent in 1997. A
third of all CARE Act clients in 2000 were women, up from 29 percent
in 1997.
Summaries of the four Public Health Reports UC-SF studies follow:
- “Responding to Racial and Ethnic Disparities in Use of HIV Drugs:
Analysis of State Policies,” by Stephen F. Morin, Sohini Sengupta,
Myrna Cozen, T. Anne Richards, Michael D. Shriver, Herminia Palacio,
and James G. Kahn, UCSF, used state surveillance and claims data to
assess trends by race/ethnicity in AIDS cases and mortality as well
as participation rates in Medicaid and the CARE Act’s AIDS Drug Assistance
Program (ADAP) in California, New York, Florida and Texas. They
found that, in most cases, the reduction of death rates among African
Americans and Latinos between 1996 and 1998 was not as dramatic as
the drop in death rates among non-Latino whites in New York, Florida
and Texas. Researchers said policy barriers that prevented greater
participation by minority Americans living with HIV/AIDS in Medicaid
and ADAP programs included Medicaid requirements for legal immigration
status and residency; limits on Medicaid eligibility based on disability
requirements; and state-imposed income and benefit limits on ADAP.
Social barriers to accessing AIDS medications included lack
of information, distrust of government, and HIV-related stigma. The
study concluded that state policies play a significant role in determining
access to HIV drugs, and that revisions to state policies can reduce
racial/ethnic disparities in pharmaceutical access.
- “Access to and Use of HIV Antiretroviral Therapy: Variation by Race/Ethnicity
in Two Public Insurance Programs in the U.S.,” by James G. Kahn, UCSF;
Xiulan Zhang, UCSF; Lanny T. Cross, New York AIDS Institute; Herminia
Palacio, San Francisco Department of Public Health; Guthrie S. Birkhead,
New York AIDS Institute; and Stephen F. Morin, UCSF, examined reimbursement
claims and AIDS surveillance data in New York, California, Florida,
and Texas to determine access to and use of highly active antiretroviral
therapy (HAART). HAART is highly effective in slowing the progression
of HIV disease to full-blown AIDS and is available through Medicaid
and ADAP. The researchers concluded that African Americans were
more likely to access HIV drugs through Medicaid than ADAP since Medicaid
participation is limited to those with poverty-level incomes and African
Americans have higher poverty rates. In addition, because Medicare
usually requires the individual to be disabled to obtain coverage,
African Americans typically seek care later in HIV-disease. Differences
in the use of HAART by race/ethnicity within state programs were small.
- “Differences by Race and/or Ethnicity on Use of Antiretrovirals
and Prophylaxis for Opportunistic Infection: A Review of the Literature,”
by Herminia Palacio, James G. Kahn, T. Anne Richards, and Stephen
F. Morin, UCSF, assessed published articles that analyzed race/ethnicity
as a predictor of antiretroviral or HIV-related medication use. Their
review concluded that there is substantial evidence of pervasive racial
disparities in antiretroviral use, which is known to be strongly associated
with positive HIV health outcomes.
- “The HIV Care Continuum in Publicly Funded Clinics,” by T. Anne
Richards, Herminia Palacio, James G. Kahn, and Stephen F. Morin, UCSF,
assessed data from HIV specialty clinics serving racial/ethnic minorities
in New York, California, Texas and Florida. Researchers found that
all of the sites tested for HIV relatively late in the disease after
infection, that treatment for HIV did not take priority over basic
family needs for people living in poverty, and that comprehensive
support services were critical in order to treat HIV. In three clinics,
the restriction of Medicaid eligibility to persons with an AIDS diagnosis
or other medically defined disability was a barrier to accessing care.
HRSA is sponsoring the four-day conference to improve systems of care
for people living with HIV/AIDS, facilitate grantee compliance with
changes in the reauthorized CARE Act, increase grantees’ knowledge of
administrative requirements, and enable them to share best practices.
# # #
Note: HRSA press releases are available on the Web at
http://newsroom.hrsa.gov.
|